FeesSafety
Pluang+

Dyadic's C1 platform antibodies for RSV and malaria enter animal studies, aiming to cut biologic drug costs.

Market News
12 Nov 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
Dyadic's C1 platform antibodies for RSV and malaria enter animal studies, aiming to cut biologic drug costs.

Dyadic International announced that the Gates Medical Research Institute has started preclinical animal studies comparing antibodies against RSV and malaria produced by Dyadic's C1 platform with traditional CHO cell-produced antibodies. These studies aim to demonstrate C1's potential as a faster, cheaper, and scalable alternative for manufacturing therapeutic antibodies, particularly benefiting low- and middle-income countries. Positive results could support further clinical development and validate the platform's broader use in biologics manufacturing. Results are expected in Q1 2027.

Dyadic's C1-produced RSV and malaria antibodies are advancing into animal studies, offering context for readers interested in health-sector developments. For readers following the health sector, here is Pluang's market snapshot as of Nov 12, 2026 19:11 WIB: out of 150 priced US health stocks, 91 rose and 53 fell. Guardant Health Inc. (GH) led with a price of USD 158.50 and a 1-day gain of +2.40%, while Nuwellis Inc (NUWE) and AdaptHealth Corp (AHCO) showed contrasting order activities and price changes, with NUWE at USD 5.66 up +2.35% but 100% sell orders, and AHCO at USD 7.62 down -2.31% also with 100% sell orders.

More News

CollPlant to trade as OPHI on Nasdaq, focusing on photonic computing with LightSolver's laser tech.

CollPlant to trade as OPHI on Nasdaq, focusing on photonic computing with LightSolver's laser tech.

CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...

Market News
Bullish
20 minutes ago
Evaxion announces its 2027 financial calendar with key dates for updates and results.

Evaxion announces its 2027 financial calendar with key dates for updates and results.

Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...

Market News
Neutral
20 minutes ago
Glider launches a permissionless platform for tokenized stocks amid public companies' rejection of SEC venues.

Glider launches a permissionless platform for tokenized stocks amid public companies' rejection of SEC venues.

Glider has introduced a global investing platform for tokenized stocks that operates permissionlessly, bypassing the SEC's Tokenized Securities Venues (TSVs) which 50 public companies recently rejected. Backed by major investors like a16z and Coinbas...

Market News
Bullish
20 minutes ago
Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...

Market News
Bullish
1 hour ago
Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App